These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis]. Galati S, Beauvillain C, Renier G, Jeannin P, Masson C, Chevailler A. Ann Biol Clin (Paris); 2008 Jun; 66(2):157-64. PubMed ID: 18390426 [Abstract] [Full Text] [Related]
3. Autoantibodies and their antigens in autoimmune hepatitis. Bogdanos DP, Mieli-Vergani G, Vergani D. Semin Liver Dis; 2009 Aug; 29(3):241-53. PubMed ID: 19675997 [Abstract] [Full Text] [Related]
4. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S. J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694 [Abstract] [Full Text] [Related]
5. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. Soós L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF, Dankó K, Kapitány A, Végvári A, Sipka S, Szegedi G, Lakos G. J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988 [Abstract] [Full Text] [Related]
6. [Assessment methods of autoantibodies in autoimmune diseases]. Zabek J. Przegl Epidemiol; 2002 Aug; 56 Suppl 4():59-66. PubMed ID: 14750264 [Abstract] [Full Text] [Related]
7. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases. Chloraki-Bobota A, Megalakaki C, Repousis P, Chalkiopoulou I, Lalaki I, Trafalis DT, Athanassiou AE, Mitsouli-Mentzikof C. J BUON; 2006 Aug; 11(4):485-9. PubMed ID: 17309182 [Abstract] [Full Text] [Related]
8. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum. Nifli AP, Notas G, Mamoulaki M, Niniraki M, Ampartzaki V, Theodoropoulos PA, Kopnitsky MJ, Castanas E. J Immunol Methods; 2006 Apr 20; 311(1-2):189-97. PubMed ID: 16554066 [Abstract] [Full Text] [Related]
9. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice. Vos PA, Bast EJ, Derksen RH. Rheumatology (Oxford); 2006 May 20; 45(5):629-35. PubMed ID: 16368728 [Abstract] [Full Text] [Related]
10. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens. Almeida González D, Cabrera de León A, Rodríguez Pérez Mdel C, Brito Díaz B, González Hernández A, García García D, Vázquez Moncholi C, Aguirre Jaime A. J Immunol Methods; 2010 Aug 31; 360(1-2):89-95. PubMed ID: 20600078 [Abstract] [Full Text] [Related]
11. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection. Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC. J Rheumatol; 2009 Apr 31; 36(4):712-6. PubMed ID: 19286846 [Abstract] [Full Text] [Related]
12. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases. Shovman O, Gilburd B, Zandman-Goddard G, Yehiely A, Langevitz P, Shoenfeld Y. Autoimmunity; 2005 Feb 31; 38(1):105-9. PubMed ID: 15804711 [Abstract] [Full Text] [Related]
13. [Detection of anti-nuclear antibodies in liver diseases by indirect immunofluorescence method and enzyme-linked immunosorbent assay]. Koizumi H, Onozuka Y, Shibata M, Sano K, Oosima Y, Miyachi K, Ueno Y. Rinsho Byori; 1999 Aug 31; 47(8):744-8. PubMed ID: 10511806 [Abstract] [Full Text] [Related]
14. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis]. Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M. Mikrobiyol Bul; 2008 Oct 31; 42(4):669-74. PubMed ID: 19149089 [Abstract] [Full Text] [Related]
15. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders. Villalta D, Bizzaro N, Da Re M, Tozzoli R, Komorowski L, Tonutti E. Autoimmunity; 2008 Feb 31; 41(1):105-10. PubMed ID: 18176872 [Abstract] [Full Text] [Related]
16. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test? Panchagnula R, Rajiv SR, Prakash J, Chandrashekara S, Suresh KP. J Clin Rheumatol; 2006 Aug 31; 12(4):172-5. PubMed ID: 16891919 [Abstract] [Full Text] [Related]
17. A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach. Tedesco A, D'Agostino D, Soriente I, Amato P, Piccoli R, Sabatini P. Autoimmun Rev; 2009 Jan 31; 8(3):233-7. PubMed ID: 18708166 [Abstract] [Full Text] [Related]
18. Detection of autoantibodies to nuclear antigens by EIA and IF techniques. Alem M, Moghadam S, Malki J, Zaidi A, Nayak N, Li TM. Allerg Immunol (Paris); 1997 Sep 31; 29(7):188, 191-4. PubMed ID: 9373708 [Abstract] [Full Text] [Related]
20. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis. Xue Y, Zhang J, Chen YM, Guan M, Zheng SG, Zou HJ. Scand J Rheumatol; 2008 Sep 31; 37(3):183-7. PubMed ID: 18465452 [Abstract] [Full Text] [Related] Page: [Next] [New Search]